432
Participants
Start Date
May 31, 2026
Primary Completion Date
February 28, 2030
Study Completion Date
December 31, 2030
Valproic Acid (VPA)
VPA (in 250 ml 0.9% sodium chloride solution)
Standard of care treatment + normal saline
Standard of care treatment + normal saline (0.9% sodium chloride solution) vehicle (250 ml)
University of Alabama at Birmingham, Birmingham
Vanderbilt University Medical Center, Nashville
Medical College of Wisconsin, Milwaukee
University of Texas Southwestern, Dallas
University of California, Davis, Sacramento
Oregon Health & Science University, Portland
University of Arizona, Tucson
University of Southern California, Los Angeles
United States Department of Defense
FED
Northwestern University
OTHER